Scott Long

Array ( [id] => 6099097 [patent_doc_number] => 20110163472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'FOAMED SOL-GEL AND METHOD OF MANUFACTURING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/984804 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6997 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20110163472.pdf [firstpage_image] =>[orig_patent_app_number] => 12984804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8614015 [patent_doc_number] => 20130019327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN' [patent_app_type] => utility [patent_app_number] => 13/519059 [patent_app_country] => US [patent_app_date] => 2010-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12173 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465102 [patent_doc_number] => 20120270271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Toxin-Immunity System' [patent_app_type] => utility [patent_app_number] => 13/516158 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23994 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10649591 [patent_doc_number] => 09365830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Agents and methods for inhibiting human pluripotent stem cell growth' [patent_app_type] => utility [patent_app_number] => 13/992931 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 73 [patent_no_of_words] => 37197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652652 [patent_doc_number] => 08372397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Methods for regulation of stem cells' [patent_app_type] => utility [patent_app_number] => 12/956726 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 41144 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12956726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6184094 [patent_doc_number] => 20110123601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'BIOFUNCTIONALIZED PHOSPHOLIPID-CAPPED MESOPOROUS SILICA NANOSHUTTLES FOR TARGETED DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/952094 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 3042 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123601.pdf [firstpage_image] =>[orig_patent_app_number] => 12952094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483716 [patent_doc_number] => 20120283124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Cell Surface Marker Expression in Hematopoietic Stem Cells and Progenitors for the Diagnosis, Prognosis, and Treatment of Myelodysplastic Syndromes' [patent_app_type] => utility [patent_app_number] => 13/508319 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8122 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7760370 [patent_doc_number] => 20120030776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 12/910746 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 156 [patent_figures_cnt] => 156 [patent_no_of_words] => 272563 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12910746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749954 [patent_doc_number] => 08841430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Use of regulatory sequences for specific, transient expression in neuronal determined cells' [patent_app_type] => utility [patent_app_number] => 12/894766 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 36 [patent_no_of_words] => 46726 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 403 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12894766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676596 [patent_doc_number] => 08815505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Use of regulatory sequences for specific, transient expression in neuronal determined cells' [patent_app_type] => utility [patent_app_number] => 12/894884 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 36 [patent_no_of_words] => 46718 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 415 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12894884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5933477 [patent_doc_number] => 20110041219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'PROMOTER, PROMOTER CONTROL ELEMENTS, AND COMBINATIONS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/891723 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37017 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20110041219.pdf [firstpage_image] =>[orig_patent_app_number] => 12891723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031186 [patent_doc_number] => 20110081403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'HISTONE OCTAMERS FOR INCREASED NUCLEIC ACID TRANSFER' [patent_app_type] => utility [patent_app_number] => 12/887666 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14454 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081403.pdf [firstpage_image] =>[orig_patent_app_number] => 12887666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202010 [patent_doc_number] => 20110064796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'CONCENTRATED, INHALABLE ANTIBIOTIC FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/888275 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16306 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064796.pdf [firstpage_image] =>[orig_patent_app_number] => 12888275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041275 [patent_doc_number] => 20120070373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHOD AND COMPOUND FOR TREATMENT OF CANCER USING PHOSPHOROUS-32 LABELED DNA' [patent_app_type] => utility [patent_app_number] => 12/886127 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5902 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070373.pdf [firstpage_image] =>[orig_patent_app_number] => 12886127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9523579 [patent_doc_number] => 08747837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Oncolytic vaccinia virus combination cancer therapy' [patent_app_type] => utility [patent_app_number] => 13/395929 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24415 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954961 [patent_doc_number] => 20110034752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'THERAPEUTIC REGIMEN FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/873737 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24369 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034752.pdf [firstpage_image] =>[orig_patent_app_number] => 12873737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7987239 [patent_doc_number] => 08075913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Method of producing a cationic liposomal preparation comprising a lipophilic compound' [patent_app_type] => utility [patent_app_number] => 12/859000 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 20306 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/075/08075913.pdf [firstpage_image] =>[orig_patent_app_number] => 12859000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5957362 [patent_doc_number] => 20110035816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Genetically Modified Rat Models for Drug Metabolism' [patent_app_type] => utility [patent_app_number] => 12/850921 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22445 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20110035816.pdf [firstpage_image] =>[orig_patent_app_number] => 12850921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9482511 [patent_doc_number] => 08728456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Programming of cells for tolerogenic therapies' [patent_app_type] => utility [patent_app_number] => 13/386950 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 64 [patent_no_of_words] => 19789 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244780 [patent_doc_number] => 08202703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Placental stem cell populations' [patent_app_type] => utility [patent_app_number] => 12/848007 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 44277 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202703.pdf [firstpage_image] =>[orig_patent_app_number] => 12848007 [rel_patent_id] =>[rel_patent_doc_number] =>)